| Gender |
| Male |
14 (54) |
| Female |
12 (46) |
| Age at diagnosis (days) |
126 ± 77.9 |
| Biliary atresia type |
| Type 1 |
0 |
| Type 2a |
6 (23) |
| Type 2b |
2 (8) |
| Type 3 |
18 (69) |
| Pre-operative body weight (kg) |
5.5 ± 2.4 |
| Pre-operative laboratory findings |
| Total bilirubin (mg/dL) |
10.8 ± 5.4 (≤ 1.0) |
| Direct bilirubin (mg/dL) |
8.4 ± 2.7 (0–0.2) |
| Alanine aminotransferase (ALT) (U/L) |
140 ± 75.1 (≤ 41) |
| Aspartate aminotransferase (AST) (U/L) |
231.7 ± 98.0 (≤ 40) |
| Alkaline phosphatase (ALP) (U/L) |
568.5 ± 249.8 (≤ 462) |
| Gamma glutamyl transferase (GGT) (U/L) |
544.4 ± 341.9 (7–64) |
| Albumin (g/dL) |
3.3 ± 0.6 (3.9–4.9) |
| International normalized ratio (INR) |
1.9 ± 1.6 (0.9–1.1) |
| White blood cells (×103/μL) |
13.9 ± 8.3 (4.5–13.5) |
| Neutrophil (%) |
41.0 ± 14.1 (35.0–65.0) |
| Lymphocyte (%) |
42.5 ± 19.4 (23.0–53.0) |
| Pre-operative portal hypertension features |
| Esophageal varices |
3 (12) |
| Splenomegaly |
10 (38) |
| Platelet (×103/μL) |
315.4 ± 176.8 (150–450) |
| Ascites |
15 (58) |
| Age at Kasai procedure performed (days) |
| < 60 |
2 (8) |
| ≥ 60 |
24 (92) |
| Histopathological findings of liver biopsy |
| Liver cirrhosis |
11 (42) |
| Non-liver cirrhosis |
15 (58) |
| Sonography findings |
| Undetectable gallbladder |
11 (42) |
| Triangular cord sign |
5 (19) |
| Outcomes |
| Survived |
15 (58) |
| Died |
11 (42) |
| Cause of death |
| Septic shock |
2 (18) |
| Pulmonary edema |
2 (18) |
| Hemorrhagic shock |
1 (9) |
| Aspiration pneumonia |
2 (18) |
| Hepatopulmonary syndrome |
1 (9) |
| Multiple organ dysfunction syndrome |
3 (27) |
